José Luis Velasco-Garrido

Statistics

Publications

Citations

H-Index

Active since

2021

Affiliations

AstraZeneca (Spain)(Current)

Hospital Quirónsalud Barcelona

Hospital Universitario Doctor Peset

Hospital Clínico Universitario Virgen de la Victoria

José Luis Velasco-Garrido is an author at AstraZeneca (Spain) specializing in eosinophilic disease therapy, pharmacotherapy, and clinical pharmacology.

Publications per year

2021–2023

Publications

Achieving clinical outcomes with benralizumab in severe eosinophilic asthma patients in a real-world setting: ORBE II study

Alicia Padilla‐Galo, Isabel Carmona, Pilar Ausín et al. · Respiratory Research · 2023 · 52 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Real-world study in severe eosinophilic asthma patients refractory to anti-IL5 biological agents treated with benralizumab in Spain (ORBE study)

Eva Martínez‐Moragón, Ismael García‐Moguel, Javier Nuevo et al. · BMC Pulmonary Medicine · 2021 · 30 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Rectus Femoris Cross-Sectional Area and Phase Angle asPredictors of 12-Month Mortality in Idiopathic Pulmonary Fibrosis Patients

Rocío Fernández‐Jiménez, Eva Cabrera César, Ana Sánchez García et al. · Nutrients · 2023 · 13 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +13

1–3 of 3